Bristol Myers Squibb Manufacturing Company

FDA Regulatory Profile

Bristol Myers Squibb Manufacturing Company appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-181-2013, Class II) was initiated on November 2, 2012.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-181-2013Class IIABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America PharmaceNovember 2, 2012